Sotac Pharmaceuticals Ltd (SOTAC) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Sotac Pharmaceuticals Ltd reported sales of ₹37.01 Cr, operating profit of ₹3.64 Cr (OPM 9.84%) and net profit of ₹2.45 Cr for the quarter ended Sep 2025. Figures in ₹ crore, consolidated where available.
SOTAC quarterly results (₹ Cr) Metric Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Mar 2025 Sep 2025 Sales - 51.64 - 52.19 - 52.59 44.39 37.01 Expenses - 47.21 - 48.1 - 48.27 35.07 33.37 Operating Profit - 4.43 - 4.09 - 4.32 9.32 3.64 OPM - 8.58% - 7.84% - 8.21% 21% 9.84% Other Income - 0.06 - 0.2 - 0.7 3.2 4.29 Interest - 0.91 - 0.8 - 1.01 1.57 1.88 Depreciation - 1.39 - 1.72 - 1.48 2.35 2.7 Profit before tax - 2.19 - 1.77 - 2.53 8.6 3.35 Tax - 45.21% - -34.46% - 29.64% 12.67% 22.69% Net Profit - 1.73 - 2.55 - 1.91 6.11 2.45 EPS in Rs - 1.57 - 2.31 - 1.73 5.53 2.22
SOTAC profit & loss, annual (₹ Cr) Metric Mar 2020 Mar 2021 Mar 2023 Mar 2024 Mar 2025 TTM Sales 28.6 48.84 76.96 103.75 96.93 81.4 Expenses 26.73 47.38 69.65 95.2 83.3 68.44 Operating Profit 1.87 1.46 7.31 8.55 13.63 12.96 OPM 6.54% 2.99% 9.5% 8.24% 14.06% 15.92% Other Income 0.22 0.11 0.93 0.25 3.9 7.49 Interest 0.33 1.03 2.04 1.74 2.58 3.45 Depreciation 1.4 2.59 2.28 3.1 3.84 5.05 Profit before tax 0.36 -2.05 3.92 3.96 11.11 11.95 Tax 75% 15.12% 41.84% 9.85% 16.65% - Net Profit 0.09 -2.37 2.29 3.58 9.28 8.56 EPS in Rs 0.39 -10.3 3.58 3.87 7.27 7.75 Dividend Payout 0% 0% 0% 0% 0% -
SOTAC balance sheet (₹ Cr) Metric Mar 2021 Mar 2023 Mar 2024 Mar 2025 Sep 2025 Equity Capital 2.3 8.05 11.05 11.05 11.05 Reserves 0.19 11.41 34.21 42.2 44.63 Borrowings 17.13 22.04 24.86 43.7 38.24 Other Liabilities 15.08 32.14 35.2 27.37 29.35 Total Liabilities 34.7 73.64 105.32 124.32 123.27 Fixed Assets 16.56 25.92 35.51 48.69 47.33 CWIP 0 0.04 5.12 0.2 0.81 Investments 0.3 0 2.1 3.78 2.68 Other Assets 17.84 47.68 62.59 71.65 72.45 Total Assets 34.7 73.64 105.32 124.32 123.27
SOTAC cash flows (₹ Cr) Metric Mar 2020 Mar 2021 Mar 2023 Mar 2024 Mar 2025 Cash from Operating Activity 0.06 -0.31 8.14 -16.08 -4.33 Cash from Investing Activity -11.75 -3.23 -11.67 -19.68 -13.62 Cash from Financing Activity 11.4 3.38 13.14 29.49 16.09 Net Cash Flow -0.29 -0.16 9.61 -6.26 -1.85 Free Cash Flow -9.74 -3.47 0.45 -33.86 -16.43 CFO/OP 17% 8% 134% -168% -26%
SOTAC ratios Metric Mar 2020 Mar 2021 Mar 2023 Mar 2024 Mar 2025 Debtor Days 88.83 43.94 69.91 92.49 128.44 Inventory Days 39.53 44.76 86.93 82.57 108.26 Days Payable 194.09 120.65 161.82 132.46 101.2 Cash Conversion Cycle -65.73 -31.95 -4.98 42.61 135.5 Working Capital Days -78.87 -43.72 -39.6 47.46 62.96 ROCE - -5.39% - 10.02% 15.06%